
COMMISSION REGULATION (EU) 2019/831 of 22 May 2019 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance) 

THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products, and in particular Article 15(1), the fourth subparagraph of Article 15(2) and Article 31(1) thereof,
Whereas:

(1) Regulation (EC) No 1272/2008 of the European Parliament and of the Council provides for a harmonised classification of substances as carcinogenic, mutagenic or toxic for reproduction (CMR) based on a scientific assessment by the Risk Assessment Committee of the European Chemicals Agency. The substances are classified as CMR substances of category 1A, CMR substances of category 1B or CMR substances of category 2 depending on the level of evidence of their CMR properties.

(2) Article 15 of Regulation (EC) No 1223/2009 provides that substances which have been classified as CMR substances of category 1A, category 1B or category 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 (CMR substances) are prohibited from use in cosmetic products. A CMR substance may however be used in cosmetic products where the conditions laid down in the second sentence of Article 15(1) or in the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This Regulation implements Regulation (EC) No 1223/2009. Only the Court of Justice of the European Union is entitled to interpret Union law, including Article 15 of Regulation (EC) No 1223/2009.

(3) In order to uniformly implement the prohibition of CMR substances within the internal market, to ensure legal certainty, in particular for economic operators and national competent authorities and to ensure a high level of protection of human health, all CMR substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. Where the conditions laid down in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled, the lists of restricted or authorised substances in Annexes III and V to that Regulation should be amended accordingly.

(4) This Regulation covers the substances which have been classified as CMR substances pursuant to Regulation (EC) No 1272/2008 as at 1 December 2018, when Commission Regulation (EU) 2017/776 became applicable.

(5) Concerning certain CMR substances for which a request for use in cosmetic products by way of exception has been submitted, it has not been established that all the conditions provided for in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This concerns Quaternium-15, Chloroacetamide, Dichloromethane, Formaldehyde, Perboric acid and Sodium perborate compounds

(6) The substance Methenamine 3-chloroallylochloride, with the International Nomenclature of Cosmetic Ingredients (INCI) name Quaternium-15, is currently listed in entry 31 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,2 % in ready for use preparation. Quaternium-15 is a mixture of cis and trans isomers of which the cis-isomer has been classified as a CMR substance of category 2 by Commission Regulation (EC) No 790/2009. The classification became applicable on 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the Scientific Committee on Consumer Safety (SCCS) and found safe for use in cosmetic products. On 13 and 14 December 2011, the SCCS issued a scientific opinion on Quaternium-15 (cis-isomer), which concluded that on the basis of the available data the safety of Quaternium-15 for use in cosmetic products cannot be established. In light of the classification of the cis-isomer present in Quaternium-15 as a CMR substance of category 2 and the opinion of the SCCS, Quaternium-15 should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(7) The substance 2-Chloroacetamide, with the INCI name Chloroacetamide, is currently listed in entry 41 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,3 % in ready for use preparation. Chloroacetamide has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010, at which date Titles II, III and IV of Regulation (EC) No 1272/2008 became applicable in respect of substances. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 22 March 2011, the SCCS issued a scientific opinion on Chloroacetamide which concluded that, on the basis of the available data, the substance is not safe for consumers when used in a concentration of up to 0,3 % w/w in cosmetic products. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, Chloroacetamide should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(8) The substance Dichloromethane is currently listed in entry 7 of Annex III to Regulation (EC) No 1223/2009 as allowed in cosmetic products in a concentration of up to 35 % in ready for use preparation. Dichloromethane has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 11 December 2012, the SCCS issued a scientific opinion on Dichloromethane. On 25 March 2015, the SCCS issued a new opinion which was revised on 28 October 2015. In that revised opinion the SCCS concluded that the use of Dichloromethane in a concentration of up to 35 % in hair sprays and its use in spray formulations in general is not considered safe for the consumer. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, and since no other uses of Dichloromethane in cosmetic products are known and have been covered by the SCCS opinion, the substance should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(9) The substance Formaldehyde is currently listed in entry 13 of Annex III to Regulation (EC) No 1223/2009 as allowed in nail hardening products in a concentration of up to 5 % in ready for use preparation. It is also currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 as allowed in oral products in a concentration of up to 0,1 % and in other products in a concentration of up to 0,2 %. Formaldehyde has been classified as a CMR substance of category 1B by Commission Regulation (EU) No 605/2014. The classification became applicable on 1 January 2016. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled, including the conditions that no suitable alternative substances are available, that an application is made for a particular use of the product category with a known exposure and that the substance has been evaluated and found safe by the SCCS. On 7 November 2014, the SCCS concluded in its opinion that ‘nail hardeners with a maximum concentration of about 2,2 % free formaldehyde can be used safely to harden or strengthen nails’. However, since it has not been established that there are no suitable alternative substances available for the purpose of hardening nails, Formaldehyde should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009. Since no application was made for other uses of Formaldehyde, the substance should be deleted from the list of preservatives allowed in cosmetic products in Annex V to that Regulation. Formaldehyde should also be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.

(10) Perboric acid and Sodium perborate compounds are covered by the hydrogen peroxide releasing substances currently listed in entry 12 of Annex III to Regulation (EC) No 1223/2009. They have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. A request for the application of the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 was submitted for the use of those substances in oxidative hair dye formulations. On 22 June 2010, the SCCS concluded in its opinion that the ‘general restrictions applicable to hydrogen peroxide releasing substances should apply to sodium perborate and perboric acid and that the use of sodium perborates as an ingredient in oxidative hair dye formulations with a maximum on-head concentration of 3 % will not pose a risk to the health of the consumer’. However, since it has not been established that there are no suitable alternative substances available for the purpose of oxidation of hair, Perboric acid and Sodium perborate compounds should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(11) Concerning certain substances which were classified as CMR substances under Regulation (EC) No 1272/2008 and for which a request for the application of the second sentence of Article 15(1) of Regulation (EC) No 1223/2009 has been submitted, it has been established that the condition provided for in that provision is fulfilled. This concerns Trimethylbenzoyl diphenylphosphine oxide, Furfural and Polyaminopropyl biguanide.

(12) The substance Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide, with the INCI name Trimethylbenzoyl diphenylphosphine oxide (TPO), is currently not included in the Annexes to Regulation (EC) No 1223/2009. TPO has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 618/2012. The classification became applicable on 1 December 2013. On 27 March 2014, the SCCS issued a scientific opinion which concluded that TPO is safe when used as a nail modelling product in a concentration of up to 5,0 % but that it is however a moderate skin sensitizer. Considering the skin sensitising properties of TPO and the high risk of exposure through skin contact in case of self-application of nail products, the use of TPO should be restricted to professionals only. In light of those elements, TPO should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 for professional use in artificial nail systems with a maximum concentration of 5 %.

(13) The substance 2-Furaldehyde, with the INCI name Furfural, is used as a fragrance or flavour ingredient in cosmetic products and is currently not included in the Annexes to Regulation (EC) No 1223/2009. It has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. On 27 March 2012, the SCCS concluded in its opinion that the use of Furfural in a concentration of up to 10 ppm (0,001 %) in ready for use preparation, including oral products, does not pose any risk to the health of the consumer. In light of the classification of Furfural as a CMR substance of category 2 and the opinion of the SCCS, Furfural should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 with a maximum concentration of 0,001 %.

(14) The substance Polyhexamethylene biguanide hydrochloride (PHMB), with the INCI name Polyaminopropyl Biguanide, is currently listed as a preservative in entry 28 of Annex V to Regulation (EC) No 1223/2009 with a maximum concentration of 0,3 %. It has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 944/2013. The classification became applicable on 1 January 2015. On 18 June 2014, the SCCS adopted an opinion which concluded that on the basis of the data available, PHMB is not safe for consumers when used as a preservative in all cosmetic products at a maximum concentration of 0,3 %. However, the SCCS opinion also concluded that the safe use could be based on a lower use concentration and/or restrictions with regard to cosmetic products' categories and that dermal absorption studies on additional representative cosmetic formulations are needed. On 7 April 2017, the SCCS adopted a new opinion which concluded that, based on the data provided, the use of PHMB as a preservative in all cosmetic products up to 0,1 % is safe but that its use in sprayable formulations is not advised. In light of the classification of PHMB as a CMR substance of category 2 and of the new SCCS opinion, PHMB should be authorised as a preservative in all cosmetic products, except in applications that may lead to exposure of the end-user's lungs by inhalation, with a maximum concentration of 0,1 %. The conditions set out in Annex V to Regulation (EC) No 1223/2009 should be adapted accordingly.

(15) Concerning a large group of substances which were classified as CMR substances under Regulation (EC) No 1272/2008, no request for use in cosmetic products by way of exception has been submitted. Those substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. This concerns, inter alia, some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009.

(16) Some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009 and Dibutyltin hydrogen borate have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled. On 22 June 2010, the SCCS issued an opinion which concluded that some of the boron compounds currently listed in entries 1a and 1b of Annex III to that Regulation are safe for use in cosmetics under certain conditions. However, since no application for a particular use was made and since it has not been established that there are no suitable alternative substances available for the purpose of the relevant uses listed in Annex III to Regulation (EC) No 1223/2009, those boron compounds should be deleted from the list of restricted substances in Annex III to that Regulation and added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009. As regards Dibutyltin hydrogen borate, no application for a particular use was made and it has not been found safe by the SCCS. That substance should therefore be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.

(17) Article 31(1) of Regulation (EC) No 1223/2009 provides that where there is a potential risk to human health, arising from the use of substances in cosmetic products, which needs to be addressed on a Community-wide basis, the Commission may, after consulting the SCCS, amend Annexes II to VI to that Regulation accordingly. The Commission has consulted the SCCS on the safety of certain substances which are similar from a chemical perspective to substances classified as CMR substances of categories 1A, 1B or 2. This concerns certain boron compounds as well as Paraformaldehyde and Methylene Glycol.

(18) Certain boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009, other than those referred to in Recital 16, have not been classified as CMR substances. On 12 December 2013, the SCCS issued an opinion on borates, tetraborates and octaborates, where it concluded that those substances, as well as other boric acid salts or esters, such as MEA-borate, MIPA-borate, potassium borate, trioctyldodecyl borate and zinc borate, form boric acid in aqueous solutions and that therefore the general restrictions applicable to boric acid should apply to the whole group of borates, tetraborates and octaborates. Boric acid has been classified as a CMR substance of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In light of the opinion of the SCCS, the whole group of borates, tetraborates and octaborates, except the substances in that group that have been classified as CMR substances, as well as other boric acid salts or esters, should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(19) The substance Paraformaldehyde is currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 but, contrary to Formaldehyde, it has not been classified as a CMR substance. The substance Methylene Glycol is currently not included in the Annexes to Regulation (EC) No 1223/2009. On 26–27 June 2012, the SCCS adopted an opinion on Methylene Glycol which established that Methylene Glycol is rapidly reversible under a variety of conditions to form Formaldehyde in aqueous solutions and that Paraformaldehyde can depolymerise to form Formaldehyde by heating or drying. In light of the opinion of the SCCS, there is a potential risk to human health arising from the use of those substances in cosmetic products. Paraformaldehyde should therefore be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and Paraformaldehyde and Methylene Glycol should be added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(20) Regulation (EC) No 1223/2009 should therefore be amended accordingly.

(21) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,
HAS ADOPTED THIS REGULATION:

Article 1 
Annexes II, III and V to Regulation (EC) No 1223/2009 are amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 22 May 2019.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX
(1) Annex II is amended as follows: 


((a)) the following entries are added:

Reference number Substance identification
Chemical name/INN CAS number EC number
a b c d
‘1385 Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC) 51229-78-8 426-020-3
1386 Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15 51229-78-8 426-020-3
1387 2-Chloracetamide 79-07-2 201-174-2
1388 Octamethylcyclotetrasiloxane 556-67-2 209-136-7
1389 Dichloromethane; methylene chloride 75-09-2 200-838-9
1390 2,2′-((3,3′,5,5′-Tetramethyl-(1,1′-biphenyl)-4,4′-diyl)-bis(oxymethylene))-bis-oxirane 85954-11-6 413-900-7
1391 Acetaldehyde; ethanal 75-07-0 200-836-8
1392 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 93107-30-3 413-760-7
1393 N-Methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone 872-50-4 212-828-1
1394 Diboron trioxide; boric oxide 1303-86-2 215-125-8
1395 Boric acid [1]Boric acid [2] 10043-35-3 [1]11113-50-1 [2] 233-139-2 [1]234-343-4 [2]
1396 Borates, tetraborates, octaborates and boric acid salts and esters, including:  
Disodium octaborate tetrahydrate [1] 12280-03-4 [1] 234-541-0 [1]
2-Aminoethanol, monoester with boric acid [2] 10377-81-8 [2] 233-829-3 [2]
2-Hydroxypropyl ammonium dihydrogen orthoborate [3] 68003-13-4 [3] 268-109-8 [3]
Potassium borate, boric acid potassium salt [4] 12712-38-8 [4] 603-184-6 [4]
Trioctyldodecyl borate [5] [5] — [5]
Zinc borate [6] 1332-07-6 [6] 215-566-6 [6]
Sodium borate, disodium tetraborate anhydrous; boric acid, sodium salt [7] 1330-43-4 [7] 215-540-4 [7]
Tetraboron disodium heptaoxide, hydrate [8] 12267-73-1 [8] 235-541-3 [8]
Orthoboric acid, sodium salt [9] 13840-56-7 [9] 237-560-2 [9]
Disodium tetraborate decahydrate; borax decahydrate [10] 1303-96-4 [10] 215-540-4 [10]
Disodium tetraborate pentahydrate; borax pentahydrate [11] 12179-04-3 [11] 215-540-4 [11]
1397 Sodium perborate [1]Sodium peroxometaborate; sodium peroxoborate [2] 15120-21-5 [1] 239-172-9 [1]
7632-04-4 [2]10332-33-9 [2]10486-00-7[2] 231-556-4 [2]
1398 Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] 13517-20-9 [1] 239-172-9 [1]
Perboric acid, sodium salt, tetrahydrate [2] 37244-98-7 [2] 234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3] 10486-00-7 [3] 231-556-4 [3]
1399 Perboric acid, sodium salt [1] 11138-47-9 [1] 234-390-0 [1]
Perboric acid, sodium salt, monohydrate [2] 12040-72-1 [2] 234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, monohydrate [3] 10332-33-9 [3] 231-556-4 [3]
1400 Dibutyltin hydrogen borate 75113-37-0 401-040-5
1401 Nickel bis(tetrafluoroborate) 14708-14-6 238-753-4
1402 Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt 8018-01-7 616-995-5
1403 Maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) 12427-38-2 235-654-8
1404 Benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate 82560-54-1 617-356-3
1405 O-Isobutyl-N-ethoxy carbonylthiocarbamate 103122-66-3 434-350-4
1406 Chlorpropham (ISO); isopropyl 3-chlorocarbanilate 101-21-3 202-925-7
1407 O-Hexyl-N-ethoxycarbonylthiocarbamate 109202-58-6 432-750-3
1408 Hydroxylammonium nitrate 13465-08-2 236-691-2
1409 (4-Ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane 105024-66-6 405-020-7
1410 Phoxim (ISO); α-(diethoxy-phosphinothioylimino) phenylacetonitrile 14816-18-3 238-887-3
1411 Glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate 77182-82-2 278-636-5
1412 Reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate — 435-960-3
1413 (4-Phenylbutyl)phosphinic acid 86552-32-1 420-450-5
1414 Reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol 170016-25-8 427-050-1
1415 Potassium titanium oxide (K2Ti6O13) 12056-51-8 432-240-0
1416 Cobalt di(acetate) 71-48-7 200-755-8
1417 Cobalt dinitrate 10141-05-6 233-402-1
1418 Cobalt carbonate 513-79-1 208-169-4
1419 Nickel dichloride 7718-54-9 231-743-0
1420 Nickel dinitrate [1] 13138-45-9 [1] 236-068-5 [1]
Nitric acid, nickel salt [2] 14216-75-2 [2] 238-076-4 [2]
1421 Nickel matte 69012-50-6 273-749-6
1422 Slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate 92129-57-2 295-859-3
1423 Slimes and sludges, copper electrolyte refining, decopperised 94551-87-8 305-433-1
1424 Nickel diperchlorate; perchloric acid, nickel(II) salt 13637-71-3 237-124-1
1425 Nickel dipotassium bis(sulfate) [1] 13842-46-1 [1] 237-563-9 [1]
Diammonium nickel bis(sulfate) [2] 15699-18-0 [2] 239-793-2 [2]
1426 Nickel bis(sulfamidate); nickel sulfamate 13770-89-3 237-396-1
1427 Nickel bis(tetrafluoroborate) 14708-14-6 238-753-4
1428 Nickel diformate [1] 3349-06-2 [1] 222-101-0 [1]
Formic acid, nickel salt [2] 15843-02-4 [2] 239-946-6 [2]
Formic acid, copper nickel salt [3] 68134-59-8 [3] 268-755-0 [3]
1429 Nickel di(acetate) [1] 373-02-4 [1] 206-761-7 [1]
Nickel acetate [2] 14998-37-9 [2] 239-086-1 [2]
1430 Nickel dibenzoate 553-71-9 209-046-8
1431 Nickel bis(4-cyclohexylbutyrate) 3906-55-6 223-463-2
1432 Nickel(II) stearate; nickel(II) octadecanoate 2223-95-2 218-744-1
1433 Nickel dilactate 16039-61-5 —
1434 Nickel(II) octanoate 4995-91-9 225-656-7
1435 Nickel difluoride [1] 10028-18-9 [1] 233-071-3 [1]
Nickel dibromide [2] 13462-88-9 [2] 236-665-0 [2]
Nickel diiodide [3] 13462-90-3 [3] 236-666-6 [3]
Nickel potassium fluoride [4] 11132-10-8 [4] — [4]
1436 Nickel hexafluorosilicate 26043-11-8 247-430-7
1437 Nickel selenate 15060-62-5 239-125-2
1438 Nickel hydrogen phosphate [1] 14332-34-4 [1] 238-278-2 [1]
Nickel bis(dihydrogen phosphate) [2] 18718-11-1 [2] 242-522-3 [2]
Trinickel bis(orthophosphate) [3] 10381-36-9 [3] 233-844-5 [3]
Dinickel diphosphate [4] 14448-18-1 [4] 238-426-6 [4]
Nickel bis(phosphinate) [5] 14507-36-9 [5] 238-511-8 [5]
Nickel phosphinate [6] 36026-88-7 [6] 252-840-4 [6]
Phosphoric acid, calcium nickel salt [7] 17169-61-8 [7] — [7]
Diphosphoric acid, nickel(II) salt [8] 19372-20-4 [8] — [8]
1439 Diammonium nickel hexacyanoferrate 74195-78-1 —
1440 Nickel dicyanide 557-19-7 209-160-8
1441 Nickel chromate 14721-18-7 238-766-5
1442 Nickel(II) silicate [1] 21784-78-1 [1] 244-578-4 [1]
Dinickel orthosilicate [2] 13775-54-7 [2] 237-411-1 [2]
Nickel silicate (3:4) [3] 31748-25-1 [3] 250-788-7 [3]
Silicic acid, nickel salt [4] 37321-15-6 [4] 253-461-7 [4]
Trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] 12519-85-6 [5] 235-688-3 [5]
1443 Dinickel hexacyanoferrate 14874-78-3 238-946-3
1444 Trinickel bis(arsenate); nickel(II) arsenate 13477-70-8 236-771-7
1445 Nickel oxalate [1] 547-67-1 [1] 208-933-7 [1]
Oxalic acid, nickel salt [2] 20543-06-0 [2] 243-867-2 [2]
1446 Nickel telluride 12142-88-0 235-260-6
1447 Trinickel tetrasulfide 12137-12-1 —
1448 Trinickel bis(arsenite) 74646-29-0 —
1449 Cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 [1] 68186-89-0 [1] 269-051-6 [1]
Cobalt nickel dioxide [2] 58591-45-0 [2] 261-346-8 [2]
Cobalt nickel oxide [3] 12737-30-3 [3] 620-395-9 [3]
1450 Nickel tin trioxide; nickel stannate 12035-38-0 234-824-9
1451 Nickel triuranium decaoxide 15780-33-3 239-876-6
1452 Nickel dithiocyanate 13689-92-4 237-205-1
1453 Nickel dichromate 15586-38-6 239-646-5
1454 Nickel(II) selenite 10101-96-9 233-263-7
1455 Nickel selenide 1314-05-2 215-216-2
1456 Silicic acid, lead nickel salt 68130-19-8 —
1457 Nickel diarsenide [1] 12068-61-0 [1] 235-103-1 [1]
Nickel arsenide [2] 27016-75-7 [2] 248-169-1 [2]
1458 Nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 68610-24-2 271-853-6
1459 Nickel dichlorate [1] 67952-43-6 [1] 267-897-0 [1]
Nickel dibromate [2] 14550-87-9 [2] 238-596-1 [2]
Ethyl hydrogen sulfate, nickel(II) salt [3] 71720-48-4 [3] 275-897-7 [3]
1460 Nickel(II) trifluoroacetate [1] 16083-14-0 [1] 240-235-8 [1]
Nickel(II) propionate [2] 3349-08-4 [2] 222-102-6 [2]
Nickel bis(benzenesulfonate) [3] 39819-65-3 [3] 254-642-3 [3]
Nickel(II) hydrogen citrate [4] 18721-51-2 [4] 242-533-3 [4]
Citric acid, ammonium nickel salt [5] 18283-82-4 [5] 242-161-1 [5]
Citric acid, nickel salt [6] 22605-92-1 [6] 245-119-0 [6]
Nickel bis(2-ethylhexanoate) [7] 4454-16-4 [7] 224-699-9 [7]
2-Ethylhexanoic acid, nickel salt [8] 7580-31-6 [8] 231-480-1 [8]
Dimethylhexanoic acid, nickel salt [9] 93983-68-7 [9] 301-323-2 [9]
Nickel(II) isooctanoate [10] 29317-63-3 [10] 249-555-2 [10]
Nickel isooctanoate [11] 27637-46-3 [11] 248-585-3 [11]
Nickel bis(isononanoate) [12] 84852-37-9 [12] 284-349-6 [12]
Nickel(II) neononanoate [13] 93920-10-6 [13] 300-094-6 [13]
Nickel(II) isodecanoate [14] 85508-43-6 [14] 287-468-1 [14]
Nickel(II) neodecanoate [15] 85508-44-7 [15] 287-469-7 [15]
Neodecanoic acid, nickel salt [16] 51818-56-5 [16] 257-447-1 [16]
Nickel(II) neoundecanoate [17] 93920-09-3 [17] 300-093-0 [17]
Bis(d.-gluconato-O1,O2)nickel [18] 71957-07-8 [18] 276-205-6 [18]
Nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2) [19] 52625-25-9 [19] 258-051-1 [19]
Nickel(II) palmitate [20] 13654-40-5 [20] 237-138-8 [20]
(2-Ethylhexanoato-O)(isononanoato-O)nickel [21] 85508-45-8 [21] 287-470-2 [21]
(Isononanoato-O)(isooctanoato-O)nickel [22] 85508-46-9 [22] 287-471-8 [22]
(Isooctanoato-O)(neodecanoato-O)nickel [23] 84852-35-7 [23] 284-347-5 [23]
(2-Ethylhexanoato-O)(isodecanoato-O)nickel [24] 84852-39-1 [24] 284-351-7 [24]
(2-Ethylhexanoato-O)(neodecanoato-O)nickel [25] 85135-77-9 [25] 285-698-7 [25]
(Isodecanoato-O)(isooctanoato-O)nickel [26] 85166-19-4 [26] 285-909-2 [26]
(Isodecanoato-O)(isononanoato-O)nickel [27] 84852-36-8 [27] 284-348-0 [27]
(Isononanoato-O)(neodecanoato-O)nickel [28] 85551-28-6 [28] 287-592-6 [28]
Fatty acids, C6-19-branched, nickel salts [29] 91697-41-5 [29] 294-302-1 [29]
Fatty acids, C8-18 and C18-unsaturated, nickel salts [30] 84776-45-4 [30] 283-972-0 [30]
2,7-Naphthalenedisulfonic acid, nickel(II) salt [31] 72319-19-8 [31] [31]
1461 Nickel(II) sulfite [1] 7757-95-1 [1] 231-827-7 [1]
Nickel tellurium trioxide [2] 15851-52-2 [2] 239-967-0 [2]
Nickel tellurium tetraoxide [3] 15852-21-8 [3] 239-974-9 [3]
Molybdenum nickel hydroxide oxide phosphate [4] 68130-36-9 [4] 268-585-7 [4]
1462 Nickel boride (NiB) [1] 12007-00-0 [1] 234-493-0 [1]
Dinickel boride [2] 12007-01-1 [2] 234-494-6 [2]
Trinickel boride [3] 12007-02-2 [3] 234-495-1 [3]
Nickel boride [4] 12619-90-8 [4] 235-723-2 [4]
Dinickel silicide [5] 12059-14-2 [5] 235-033-1 [5]
Nickel disilicide [6] 12201-89-7 [6] 235-379-3 [6]
Dinickel phosphide [7] 12035-64-2 [7] 234-828-0 [7]
Nickel boron phosphide [8] 65229-23-4 [8] — [8]
1463 Dialuminium nickel tetraoxide [1] 12004-35-2 [1] 234-454-8 [1]
Nickel titanium trioxide [2] 12035-39-1 [2] 234-825-4 [2]
Nickel titanium oxide [3] 12653-76-8 [3] 235-752-0 [3]
Nickel divanadium hexaoxide [4] 52502-12-2 [4] 257-970-5 [4]
Cobalt dimolybdenum nickel octaoxide [5] 68016-03-5 [5] 268-169-5 [5]
Nickel zirkonium trioxide [6] 70692-93-2 [6] 274-755-1 [6]
Molybdenum nickel tetraoxide [7] 14177-55-0 [7] 238-034-5 [7]
Nickel tungsten tetraoxide [8] 14177-51-6 [8] 238-032-4 [8]
Olivine, nickel green [9] 68515-84-4 [9] 271-112-7 [9]
Lithium nickel dioxide [10] 12031-65-1 [10] 620-400-4 [10]
Molybdenum nickel oxide [11] 12673-58-4 [11] — [11]
1464 Cobalt lithium nickel oxide — 442-750-5
1465 Molybdenum trioxide 1313-27-5 215-204-7
1466 Dibutyltin dichloride; (DBTC) 683-18-1 211-670-0
1467 4,4′-Bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane 151882-81-4 418-770-5
1468 Furfuryl alcohol 98-00-0 202-626-1
1469 1,2-Epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide 106-87-6 203-437-7
1470 6-Glycidyloxynapht-1-yl oxymethyloxirane 27610-48-6 429-960-2
1471 2-(2-Aminoethylamino)ethanol; (AEEA) 111-41-1 203-867-5
1472 1,2-Diethoxyethane 629-14-1 211-076-1
1473 2,3-Epoxypropyltrimethylammonium chloride; glycidyl trimethylammonium chloride 3033-77-0 221-221-0
1474 1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride 214353-17-0 433-580-2
1475 (E)-3-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol 82413-20-5 428-010-4
1476 4,4′-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol 13595-25-0 428-970-4
1477 2-Chloro-6-fluoro-phenol 2040-90-6 433-890-8
1478 2-Methyl-5-tert-butylthiophenol — 444-970-7
1479 2-Butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one 94723-86-1 425-150-8
1480 Profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one 139001-49-3 604-105-8
1481 Tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one 149979-41-9 604-715-4
1482 Cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione 5571-36-8 427-230-8
1483 Androsta-1,4,9(11)-triene-3,17-dione 15375-21-0 433-560-3
1484 Reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) — 415-930-6
1485 1,2-Benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich 71888-89-6 276-158-1
1486 Reaction mass of: diester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) — 427-140-9
1487 Diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate 150202-11-2 422-670-7
1488 3-Oxoandrost-4-ene-17-β-carboxylic acid 302-97-6 414-990-0
1489 (Z)-2-Methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid 64485-90-1 431-520-1
1490 Trisodium nitrilotriacetate 5064-31-3 225-768-6
1491 2-Ethylhexyl-2-ethylhexanoate 7425-14-1 231-057-1
1492 Diisobutyl phthalate 84-69-5 201-553-2
1493 Perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid [1] 1763-23-1 [1] 217-179-8 [1]
Potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate [2] 2795-39-3 [2] 220-527-1 [2]
Diethanolamine perfluorooctane sulfonate [3] 70225-14-8 [3] 274-460-8 [3]
Ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate [4] 29081-56-9 [4] 249-415-0 [4]
Lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] 29457-72-5 [5] 249-644-6 [5]
1494 Ethyl 1-(2,4-dichlorophenyl)5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate 103112-35-2 401-290-5
1495 1-Bromo-2-methylpropyl propionate 158894-67-8 422-900-6
1496 Chloro-1-ethylcyclohexyl carbonate 99464-83-2 444-950-8
1497 6,6′-Bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) — 441-550-5
1498 Trifluralin (ISO); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine; 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline; N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline 1582-09-8 216-428-8
1499 4-Mesyl-2-nitrotoluene 1671-49-4 430-550-0
1500 Triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate 221354-37-6 432-270-4
1501 Reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate 163879-69-4 438-310-7
1502 N,N′-Diacetylbenzidine 613-35-4 210-338-2
1503 Cyclohexylamine 108-91-8 203-629-0
1504 Piperazine 110-85-0 203-808-3
1505 Hydroxylamine 7803-49-8 232-259-2
1506 Hydroxylammonium chloride; hydroxylamine hydrochloride [1] 5470-11-1 [1] 226-798-2 [1]
Bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] 10039-54-0 [2] 233-118-8 [2]
1507 Methyl-phenylene diamine; diaminotoluene — —
1508 Mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine 110235-47-7 600-951-7
1509 Hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) [1] 10046-00-1 [1] 233-154-4 [1]
Hydroxylamine phosphate [2] 20845-01-6 [2] 244-077-0 [2]
Hydroxylamine dihydrogenphosphate [3] 19098-16-9 [3] 242-818-2 [3]
Hydroxylamine 4-methylbenzenesulfonate [4] 53933-48-5 [4] 258-872-5 [4]
1510 (3-Chloro-2-hydroxypropyl) trimethylammonium chloride 3327-22-8 222-048-3
1511 Biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine 91-95-2 202-110-6
1512 Piperazine hydrochloride [1] 6094-40-2 [1] 228-042-7 [1]
Piperazine dihydrochloride [2] 142-64-3 [2] 205-551-2 [2]
Piperazine phosphate [3] 1951-97-9 [3] 217-775-8 [3]
1513 3-(Piperazin-1-yl)-benzo[d]isothiazole hydrochloride 87691-88-1 421-310-6
1514 2-Ethylphenylhydrazine hydrochloride 19398-06-2 421-460-2
1515 (2-Chloroethyl)(3-hydroxypropyl)ammonium chloride 40722-80-3 429-740-6
1516 4-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride 159939-85-2 425-030-5
1517 Chloro-N,N-dimethylformiminium chloride 3724-43-4 425-970-6
1518 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one 199327-61-2 429-400-7
1519 Reaction products of diisopropanolamine with formaldehyde (1:4) 220444-73-5 432-440-8
1520 3-Chloro-4-(3-fluorobenzyloxy)aniline 202197-26-0 445-590-4
1521 Ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 1239-45-8 214-984-6
1522 (R,S)-2-Amino-3,3-dimethylbutane amide 144177-62-8 447-860-7
1523 3-Amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine 132-32-1 205-057-7
1524 (6R-trans)-1-((7-Ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide 100988-63-4 423-260-0
1525 Forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea 68157-60-8 614-346-0
1526 Tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea 7226-23-5 230-625-6
1527 Quinoline 91-22-5 202-051-6
1528 Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone 65277-42-1 265-667-4
1529 Metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 125116-23-6 603-031-3
1530 Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate 183196-57-8 418-260-2
1531 N,N′,N′-Tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine 26157-73-3 435-010-8
1532 Trimethylopropane tri(3-aziridinylpropanoate); (TAZ) 52234-82-9 257-765-0
1533 4,4′-Methylenediphenyl diisocyanate; diphenylmethane-4,4′-diisocyanate [1] 101-68-8 [1] 202-966-0 [1]
2,2′-Methylenediphenyl diisocyanate; diphenylmethane-2,2′-diisocyanate [2] 2536-05-2 [2] 219-799-4 [2]
o-(p-Isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4′-diisocyanate [3] 5873-54-1 [3] 227-534-9 [3]
Methylenediphenyl diisocyanate [4] 26447-40-5 [4] 247-714-0 [4]
1534 Cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate 142891-20-1 604-318-6
1535 N-[6,9-Dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide 84245-12-5 424-550-1
1536 Dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide 149961-52-4 604-712-8
1537 N,N-(Dimethylamino)thioacetamide hydrochloride 27366-72-9 435-470-1
1538 Reaction mass of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′- biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3- oxo-butanamide  434-330-5
1539 Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene 85536-20-585536-19-290641-12-690989-38-191995-20-992062-36-791995-61-8101316-63-693821-38-690641-02-4101316-62-590641-03-565996-79-4101794-90-590640-87-284650-03-365996-82-990641-01-365996-87-490640-99-668391-11-792062-33-491082-52-968937-63-392062-28-792062-27-691082-53-091995-31-291995-35-691995-66-3122070-79-5122070-80-865996-78-394114-52-094114-53-194114-54-294114-56-494114-57-590641-11-58006-61-98030-30-68032-32-464741-41-964741-42-064741-46-464742-89-868410-05-968514-15-868606-11-168783-12-068921-08-4101631-20-364741-64-664741-65-764741-66-864741-70-464741-84-064741-92-068410-71-968425-35-468527-27-591995-53-892045-49-392045-55-192045-58-492045-64-2101316-67-064741-54-464741-55-568476-46-068783-09-591995-50-592045-50-692045-59-592128-94-4101794-97-2101896-28-064741-63-564741-68-068475-79-668476-47-168478-15-968513-03-168513-63-368514-79-468919-37-968955-35-185116-58-191995-18-593571-75-693572-29-393572-35-193572-36-264741-74-864741-83-967891-79-667891-80-968425-29-668475-70-768603-00-968603-01-068603-03-268955-29-392045-65-364742-48-964742-49-064742-73-068410-96-868410-97-968410-98-068512-78-785116-60-585116-61-692045-51-792045-52-892045-57-392045-61-992062-15-293165-55-093763-33-893763-34-964741-47-564741-48-664741-69-164741-78-264741-87-364742-15-064742-22-964742-23-064742-66-164742-83-264742-95-668131-49-768477-34-968477-50-968477-53-268477-55-468477-61-268477-89-468478-12-668478-16-068513-02-068516-20-168527-21-968527-22-068527-23-168527-26-468603-08-768606-10-068783-66-468919-39-168921-09-585116-59-286290-81-590989-42-791995-38-991995-41-491995-68-592045-53-992045-60-892045-62-092045-63-192201-97-393165-19-694114-03-195009-23-797926-43-798219-46-698219-47-7101316-56-7101316-66-9101316-76-1101795-01-1102110-14-568476-50-668476-55-190989-39-2 287-502-5287-500-4292-636-2292-694-9295-281-1295-551-9295-323-9309-868-8298-725-2292-625-2309-867-2292-626-8266-013-0309-971-8292-609-5283-483-2266-016-7292-624-7266-021-4292-622-6269-929-9295-548-2293-766-2273-077-3295-543-5295-541-4293-767-8295-292-1295-295-8295-329-1310-170-0310-171-6266-012-5302-688-0302-689-6302-690-1302-692-2302-693-8292-635-7232-349-1232-443-2232-453-7265-041-0265-042-6265-046-8265-192-2270-077-5271-025-4271-727-0272-186-3272-931-2309-945-6265-066-7265-067-2265-068-8265-073-5265-086-6265-095-5270-088-5270-349-3271-267-0295-315-5295-430-0295-436-3295-440-5295-446-8309-871-4265-055-7265-056-2270-686-6272-185-8295-311-3295-431-6295-441-0295-794-0309-974-4309-987-5265-065-1265-070-9270-660-4270-687-1270-794-3270-993-5271-008-1271-058-4272-895-8273-271-8285-509-8295-279-0297-401-8297-458-9297-465-7297-466-2265-075-6265-085-0267-563-4267-565-5270-344-6270-658-3271-631-9271-632-4271-634-5273-266-0295-447-3265-150-3265-151-9265-178-6270-092-7270-093-2270-094-8270-988-8285-511-9285-512-4295-432-1295-433-7295-438-4295-443-1295-529-9296-942-7297-852-0297-853-6265-047-3265-048-9265-071-4265-079-8265-089-2265-115-2265-122-0265-123-6265-170-2265-187-5265-199-0268-618-5270-725-7270-735-1270-736-7270-738-8270-741-4270-771-8270-791-7270-795-9270-991-4271-138-9271-262-3271-263-9271-264-4271-266-5271-635-0271-726-5272-206-0272-896-3272-932-8285-510-3289-220-8292-698-0295-298-4295-302-4295-331-2295-434-2295-442-6295-444-7295-445-2296-028-8296-903-4302-639-3305-750-5308-261-5308-713-1308-714-7309-862-5309-870-9309-879-8309-976-5310-012-0270-690-8270-695-5292-695-4
1540 Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,005 % w/w benzo[a]pyrene  
  90640-85-092061-93-390640-84-961789-28-470321-79-8122384-77-470321-80-1 292-606-9295-506-3292-605-3263-047-8274-565-9310-189-4274-566-4
1541 Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene or if they contain ≥ 0,005 % w/w benzo[a]pyrene  
  85029-51-284650-04-484989-09-391995-49-2121620-47-1121620-48-290640-90-790641-04-6101896-27-9101794-91-691995-48-190641-05-784989-12-8121620-46-090640-81-690640-82-792061-92-291995-15-291995-16-391995-17-4101316-87-4122384-78-584988-93-290640-88-365996-83-090640-89-490641-06-865996-85-2101316-86-392062-22-196690-55-084989-04-884989-05-984989-06-084989-03-784989-07-168477-23-668555-24-891079-47-992062-26-594114-29-190641-00-268513-87-170321-67-492062-29-8100801-63-6100801-65-8100801-66-973665-18-668815-21-465996-86-365996-84-1 285-076-5283-484-8284-898-1295-310-8310-166-9310-167-4292-612-1292-627-3309-985-4309-972-3295-309-2292-628-9284-901-6310-165-3292-603-2292-604-8295-505-8295-275-9295-276-4295-278-5309-889-2310-191-5284-881-9292-610-0266-017-2292-611-6292-629-4266-019-3309-888-7295-536-7306-251-5284-892-9284-893-4284-895-5284-891-3284-896-0270-713-1271-418-0293-435-2295-540-9302-662-9292-623-1271-020-7274-560-1295-544-0309-745-9309-748-5309-749-0277-567-8272-361-4266-020-9266-018-8
1542 Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w 1,3-butadiene  
  68607-11-468783-06-268814-67-568814-90-468911-58-068911-59-168919-01-768919-02-868919-03-968919-04-068919-07-368919-08-468919-11-968919-12-068952-79-468952-80-768955-33-968989-88-892045-15-392045-16-492045-17-592045-18-692045-19-792045-20-068131-75-968307-98-268307-99-368308-00-968308-01-068308-10-168308-03-268308-04-368308-05-468308-06-568308-07-668308-09-868308-11-268308-12-368409-99-468475-57-068475-58-168475-59-268475-60-568476-26-668476-29-968476-40-468476-42-668476-49-368476-85-768476-86-868477-33-868477-35-068477-69-068477-70-368477-71-468477-72-568308-08-7 271-750-6272-182-1272-338-9272-343-6272-775-5272-776-0272-873-8272-874-3272-875-9272-876-4272-880-6272-881-1272-884-8272-885-3273-173-5273-174-0273-269-7273-563-5295-397-2295-398-8295-399-3295-400-7295-401-2295-402-8268-629-5269-617-2269-618-8269-619-3269-620-9269-630-3269-623-5269-624-0269-625-6269-626-1269-627-7269-629-8269-631-9269-632-4270-071-2270-651-5270-652-0270-653-6270-654-1270-667-2270-670-9270-681-9270-682-4270-689-2270-704-2270-705-8270-724-1270-726-2270-750-3270-751-9270-752-4270-754-5269-628-2
1543 Tris[2-chloro-1-(chloromethyl)ethyl] phosphate 13674-87-8 237-159-2
1544 Indium phosphide 22398-80-7 244-959-5
1545 Trixylyl phosphate 25155-23-1 246-677-8
1546 Hexabromocyclododecane [1] 25637-99-4 [1] 247-148-4 [1]
1,2,5,6,9,10-Hexabromocyclododecane [2] 3194-55-6 [2] 221-695-9 [2]
1547 Tetrahydrofuran 109-99-9 203-726-8
1548 Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] 71751-41-2 [1] 615-339-5 [1]
Avermectin B1a [2] 65195-55-3 [2] 265-610-3 [2]
1549 4-tert-Butylbenzoic acid 98-73-7 202-696-3
1550 Leucomalachite green; N,N,N′,N′-tetramethyl-4,4′-benzylidenedianiline 129-73-7 204-961-9
1551 Fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole 3878-19-1 223-404-0
1552 Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide 67129-08-2 266-583-0
1553 Di-tert-butyl peroxide 110-05-4 203-733-6
1554 Trichloromethylstannane 993-16-8 213-608-8
1555 2-Ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 57583-34-3 260-828-5
1556 2-Ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 15571-58-1 239-622-4
1557 Sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione 99105-77-8 619-394-6
1558 Bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate 82657-04-3 617-373-6
1559 Dihexyl phthalate 84-75-3 201-559-5
1560 Ammonium pentadecafluorooctanoate 3825-26-1 223-320-4
1561 Perfluorooctanoic acid 335-67-1 206-397-9
1562 N-Ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one 2687-91-4 220-250-6
1563 Proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one 189278-12-4 606-168-7
1564 Gallium arsenide 1303-00-0 215-114-8
1565 Vinyl acetate 108-05-4 203-545-4
1566 Aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline 74070-46-5 277-704-1
1567 2-Ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 57583-35-4 260-829-0
1568 Dimethyltin dichloride 753-73-1 212-039-2
1569 4-Vinylcyclohexene 100-40-3 202-848-9
1570 Tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one 87820-88-0 618-075-9
1571 Cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 101205-02-1 405-230-9
1572 Fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine 79622-59-6 616-712-5
1573 Penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole 66246-88-6 266-275-6
1574 Fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate 72490-01-8 276-696-7
1575 Styrene 100-42-5 202-851-5
1576 Tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol 97-99-4 202-625-6
1577 Formaldehyde 50-00-0 200-001-8
1578 Paraformaldehyde 30525-89-4 608-494-5
1579 Methanediol; methylene glycol 463-57-0 207-339-5
1580 Cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 57966-95-7 261-043-0
1581 Tributyltin compounds — —
1582 Tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione 335104-84-2 608-879-8
1583 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear 68515-50-4 271-093-5
1584 Spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate 203313-25-1 606-523-6
1585 Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate 31717-87-0 250-778-2
1586 Triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoate 126535-15-7 603-146-9
1587 Imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 35554-44-0 252-615-0
1588 Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 1593-77-7 216-474-9
1589 Imidazole 288-32-4 206-019-2
1590 Lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione 2164-08-1 218-499-0
1591 Metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide 139528-85-1 604-145-6
1592 2-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-one 71868-10-5 400-600-6
1593 2,3-Epoxypropyl methacrylate; glycidyl methacrylate 106-91-2 203-441-9
1594 Spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amine 118134-30-8 601-505-4
1595 Cyanamide; carbanonitril 420-04-2 206-992-3
1596 Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 94361-06-5 619-020-1
1597 Silver zinc zeolite 130328-20-0 603-404-0
1598 Cadmium carbonate 513-78-0 208-168-9
1599 Cadmium hydroxide; cadmium dihydroxide 21041-95-2 244-168-5
1600 Cadmium nitrate; cadmium dinitrate 10325-94-7 233-710-6
1601 Dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannane 77-58-7 201-039-8
1602 Clorofene; chlorophene; 2-benzyl-4-chlorophenol 120-32-1 204-385-8
1603 Anthraquinone 84-65-1 201-549-0
1604 Nonadecafluorodecanoic acid [1] 335-76-2 [1] 206-400-3[1]
Ammonium nonadecafluorodecanoate [2] 3108-42-7 [2] 221-470-5 [2] [3]
Sodium nonadecafluorodecanoate [3] 3830-45-3 [3] 
1605 N,N′-Methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-Methylenebismorpholine]; [MBM]if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w 5625-90-1 227-062-3
1606 Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2); [formaldehyde released from 3,3′-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO]if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w — —
1607 Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1)); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT]if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w — —
1608 Methylhydrazine 60-34-4 200-471-4
1609 Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol 55219-65-3 259-537-6
1610 Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide 111988-49-9 601-147-9
1611 Carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamate 16118-49-3 240-286-6’
((b)) entry 395 is replaced by the following:

Reference number Substance identification
Chemical name/INN CAS number EC number
‘395 Hydroxy-8-quinoline and its sulphate 148-24-2134-31-6 205-711-1205-137-1’

(2) Annex III is amended as follows: 


((a)) entries 1a, 1b, 7, 13 and 51 are deleted;
((b)) entry 12 is replaced by the following;

Reference number Substance identification Restrictions Wording of conditions of use and warnings
Chemical name/INN Name of Common Ingredients Glossary CAS number EC number Product type, body parts Maximum concentration in ready for use preparation Other
a b c d e f g h i
‘12 Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide, including carbamide peroxide and zinc peroxide, with the exception of the following substances in Annex II:
— No 1397, 1398, 1399 Hydrogen peroxide 7722-84-1 231-765-0  (a) Hair products
  (a) 12 % of H2O2 (40 volumes), present or released
  (a) (f) Wear suitable gloves(a) (b) (c) (e)Contains hydrogen peroxideAvoid contact with eyesRinse immediately if product comes into contact with them.
 (b) Skin products
  (b) 4 % of H2O2, present or released

 (c) Nail hardening products
  (c) 2 % of H2O2, present or released

 (d) Oral products, including mouth rinse, tooth paste and tooth whitening or bleaching products
  (d) ≤ 0,1 % of H2O2, present or released

 (e) Tooth whitening or bleaching products
  (e) > 0,1 % ≤ 6 % of H2O2, present or released
  (e) To be only sold to dental practitioners. For each cycle of use, first use by dental practitioners as defined under Directive 2005/36/EC of the European Parliament and of the Council or under their direct supervision if an equivalent level of safety is ensured. 

Afterwards to be provided to the consumer to complete the cycle of use.

Not to be used on a person under 18 years of age.
  (e) Concentration of H2O2 present or released indicated in percentage. 

Not to be used on a person under 18 years of age.

To be only sold to dental practitioners. For each cycle of use, the first use to be only done by dental practitioners or under their direct supervision if an equivalent level of safety is ensured.

Afterwards to be provided to the consumer to complete the cycle of use.

 (f) Products intended for eyelashes
  (f) 2 % of H2O2, present or released
  (f) For professional use only
  f) To be printed on the label: 


 For professional use only.
 Avoid contact with eyes.
 Rinse eyes immediately if product comes into contact with them.
 Contains hydrogen peroxide


((c)) the following entries are added:

Ref No. Substance identification Restrictions Wording of conditions of use and warnings
Chemical name/INN Name of Common Ingredients Glossary CAS number EC number Product type, body parts Maximum concentration in ready for use preparation Other 
a b c d e f g h i
‘311 Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide Trimethylbenzoyl diphenylphosphine oxide 75980-60-8 278-355-8 Artificial nail systems 5,0 % Professional use For professional use onlyAvoid skin contactRead directions for use carefully
312 2-Furaldehyde Furfural 98-01-1 202-627-7  0,001 %’  

(3) Annex V is amended as follows: 


((a)) point 2 of the preamble is replaced by the following:
' 2. All finished products containing substances in this Annex and which release formaldehyde must be labelled with the warning ‘contains formaldehyde’ where the concentration of formaldehyde in the finished product exceeds 0,05 %
'
((b)) entries 5, 31, 40 and 41 are deleted;
((c)) entry 28 is replaced by the following:

Reference number Substance Identification Conditions Wording of conditions of use and warnings
Chemical name/INN Name of Common Ingredients Glossary CAS number EC number Product type, Body parts Maximum concentration in ready for use preparation Other 
a b c d e f g h i
‘28 Polyhexamethylene biguanide hydrochloride Polyaminopropyl biguanide 32289-58-0,27083-27-8,28757-47-3,133029-32-0 608-723-9608-042-7  0,1 % Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation’ 
